These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24627145)

  • 1. The spatial profile of macular pigment in subjects from a Singapore Chinese population.
    Neelam K; Ho H; Yip CC; Li W; Eong KG
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2376-83. PubMed ID: 24627145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A central dip in the macular pigment spatial profile is associated with age and smoking.
    Kirby ML; Beatty S; Loane E; Akkali MC; Connolly EE; Stack J; Nolan JM
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6722-8. PubMed ID: 20592234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
    Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
    Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM
    Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
    Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
    Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing.
    Nolan JM; Kenny R; O'Regan C; Cronin H; Loughman J; Connolly EE; Kearney P; Loane E; Beatty S
    Ophthalmic Res; 2010; 44(2):131-9. PubMed ID: 20516725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
    Richer S; Devenport J; Lang JC
    Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population.
    Beatty S; Murray IJ; Henson DB; Carden D; Koh H; Boulton ME
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):439-46. PubMed ID: 11157880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
    Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
    Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary modification of human macular pigment density.
    Hammond BR; Johnson EJ; Russell RM; Krinsky NI; Yeum KJ; Edwards RB; Snodderly DM
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1795-801. PubMed ID: 9286268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum.
    Nolan JM; Stack J; O'connell E; Beatty S
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):571-82. PubMed ID: 17251452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration.
    Ciulla TA; Hammond BR
    Am J Ophthalmol; 2004 Oct; 138(4):582-7. PubMed ID: 15488784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.
    Nolan JM; O'Reilly P; Loughman J; Stack J; Loane E; Connolly E; Beatty S
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4777-85. PubMed ID: 19628740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial profile of macular pigment and its relationship to foveal architecture.
    Nolan JM; Stringham JM; Beatty S; Snodderly DM
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2134-42. PubMed ID: 18436846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.
    Degli Esposti S; Egan C; Bunce C; Moreland JD; Bird AC; Robson AG
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6568-75. PubMed ID: 22899764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular pigment and percentage of body fat.
    Nolan J; O'Donovan O; Kavanagh H; Stack J; Harrison M; Muldoon A; Mellerio J; Beatty S
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):3940-50. PubMed ID: 15505040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of macular pigment in patients with age-related macular degeneration and healthy control subjects - a study using spectral fundus reflectance.
    Kaya S; Weigert G; Pemp B; Sacu S; Werkmeister RM; Dragostinoff N; Garhöfer G; Schmidt-Erfurth U; Schmetterer L
    Acta Ophthalmol; 2012 Aug; 90(5):e399-403. PubMed ID: 23035764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between macular pigment and visual acuity in eyes with early age-related macular degeneration.
    Puell MC; Palomo-Alvarez C; Barrio AR; Gómez-Sanz FJ; Pérez-Carrasco MJ
    Acta Ophthalmol; 2013 Jun; 91(4):e298-303. PubMed ID: 23575039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macular pigment and healthy vision.
    Optometry; 2009 Oct; 80(10):592-8. PubMed ID: 20576249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E genotype is associated with macular pigment optical density.
    Loane E; McKay GJ; Nolan JM; Beatty S
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2636-43. PubMed ID: 20107178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.